Oncode Scientific

OUR UNWAVERING COMMITMENT

DELIVERING OPTIMAL SOLUTIONS

At the core of our mission lies an unwavering commitment to patients’ well-being. We tirelessly seek and craft the most effective solutions, ensuring that every patient receives the Right Drug at the Right Time, Every Time.

THE COMPANY​

ONCODE SCIENTIFIC SDN BHD

Established in 2015, ONCODE Scientific Sdn Bhd is a distinguished precision medicine laboratory at the forefront of cancer molecular diagnostics. ONCODE brings together a distinguished team of seasoned experts from various disciplines, encompassing molecular science, pathology, genetics, clinical practice, pharmacy, bioinformatics, and business. With decades of cumulative experience in medical diagnostics and clinical research, the company harnesses an extensive wealth of expertise.
ONCODE has set up world-class facilities in Malaysia, solidifying its position as the first precision medicine center dedicated to both solid tumours and blood cancers. Guided by a spirit of continuous innovation, the company challenges conventional norms and surpasses expectations, paving the way to becoming one of the world’s foremost molecular diagnostic laboratories.
The company’s unwavering commitment to excellence drives its mission to create groundbreaking medical solutions that seamlessly integrate disease prevention, detection, interpretation, and intervention. Firmly believing in the power of precision medicine, ONCODE strives to deliver the highest quality and affordable molecular diagnostic solutions to the global community, propelling transformative advancements in healthcare.

OUR MISSION

  1. To provide accurate and timely diagnostic services that contribute to the well-being and improved health outcomes of patients.

  2. To support healthcare professionals in their diagnostic decision-making, promote early disease detection, facilitate effective treatment strategies, and ultimately enhance the overall quality of patient care through unwavering dedication to quality, precision, and innovation.

  3. To make a positive and lasting impact on the lives of individuals and the communities we serve by continually advancing scientific knowledge, embracing cutting-edge technologies, and upholding the highest standards of ethical practice.

  1. To provide accurate and timely diagnostic services that contribute to the well-being and improved health outcomes of patients.

  2. To support healthcare professionals in their diagnostic decision-making, promote early disease detection, facilitate effective treatment strategies, and ultimately enhance the overall quality of patient care through unwavering dedication to quality, precision, and innovation.

  3. To make a positive and lasting impact on the lives of individuals and the communities we serve by continually advancing scientific knowledge, embracing cutting-edge technologies, and upholding the highest standards of ethical practice.

OUR VISION

Our unwavering aspiration is to establish ourselves as a preeminent global leader among molecular diagnostic laboratories, propelled by relentless innovation and a fearless pursuit of groundbreaking advancements. By fearlessly pushing the boundaries of what is possible, embracing transformative change, and exceeding all expectations, we strive to set new standards in the field, shaping the future of molecular diagnostics and revolutionizing healthcare on a global scale.

THE LABORATORY​

ONCODE Laboratory

Oncode laboratory workflows and pipelines adhere to stringent internal and external validations, ensuring the highest quality and compliance with esteemed international guidelines and standards, including Good Laboratory Practice (GLP), ISO 15189, and renowned organizations such as the Association for Molecular Pathology (AMP) and the College of American Pathologists (CAP). Oncode stands as a distinguished ISO 15189 accredited laboratory, renowned for its certification in the specialized field of molecular testing.

The laboratory actively participates in external quality assurance and proficiency programs, such as the UK National External Quality Assurance System (UKNEQAS), the European Molecular Genetics Quality Network (EMQN), the Royal College of Pathologists of Australasia (RCPA), and the College of American Pathologists (CAP). Through these initiatives, the laboratory continuously assesses and refines its practices, ensuring unparalleled accuracy and reliability in its diagnostic services.

Executive Leadership

CEO-Dr-Lim-Su-Wen_circlev2
Assoc. Prof Dr Lim Su Wen (PhD)
Founder & Chief Executive Officer
COO-Dr-Kow-Koon-Kee_circlev2
Dr. Kow Koon Kee (PhD)
Co-Founder, VP & Chief Operating Officer
CMO-Dr-Mani_circle
Dr. Subramanian Yegappan (MBBS)
VP & Chief Medical Officer
HKP-Amy-Teh-circlev2
Dr. Amy Teh (PhD)
Chief Strategy & Project Officer
HTP-Goh-Share-Yuen-circlev2
Dr. Goh Share Yuan (PhD)
Chief Scientific Officer
Picture3
Mr. Dave Ling (MSc & RPh)
Chief Commercial Officer
Picture2
Mr. Loke Chee Kien (CA, CPA, MBA)
Chief Financial Officer
HOA-Ying-circlev2
Ms. Ying
Accounts Director
HTA-Kathy-circlev2
Ms. Kathy
Administrative Director

Advisory Board

ho-gwo-fuang-250x250
Prof Dr. Ho Gwo Fuang
MBBS (UK), MRCP (UK), FRCR (Lond), BSc (Scot), MBChB (UK)
Advisor (Oncology)
Dato dr Chang Kian Meng
Dato Dr. Chang Kian Meng
MBBS (Mal), MRCP (UK), FRCP (Lon), FRCPA (Haem) Aust
Advisor (Hematology & Transplant)
Dr-Tho-3-min
Dr. Tho Lye Mun
MBBS (Sydney), MRCP (UK), FRCR (UK), PhD (Glasgow), CCT (UK), Fellowship in Molecular Oncology (UK)
Advisor (Oncology)
DSC00856
Dr. Habibah Binti Abdul Halim
BA (UK), MA (UK), MBBCh (UK), MRCP (UK), FRCPATH (Hema)(UK), Fellowship in Hematology (Malaysia)
Advisor (Pathology & Hematology)
Professor Dr Loh Hwei San
Professor Dr. Loh Hwei San
PhD, University of Nottingham
Scientific Advisor

Top Management Team

CEO Dr Lim Su Wen_circle
Dr Lim Su Wen (PhD)
Founder & Chief Executive Officer
CMO Dr Mani_circle
Dr Subramanian Yegappan (MBBS)
Chief Medical Officer & Pathologist
COO Dr Kow Koon Kee_circle
Dr Kow Koon Kee (PhD)
Chief Operating Officer